Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Guideline: Page 2
Natera announces results for NIPT in twin-pregnancy clinical study
By
LabPulse.com staff writers
Using single-nucleotide polymorphism technology, the test analyzes fetal DNA obtained through a blood draw from the mother.
December 7, 2022
Stop: Don't order these tests
By
LabPulse.com staff writers
Industry organizations have collaborated on recommendations to ensure patients receive the right testing at the right time.
November 8, 2022
FDA proposes updates to breakthrough devices guidance focused on reducing disparities in healthcare
By
LabPulse.com staff writers
The agency is proposing updates to clarify considerations in designating devices, including eligible devices that may benefit populations impacted by disparities in healthcare.
October 20, 2022
Exact Sciences awards $525K in grants to improve CRC screening
By
LabPulse.com staff writers
Exact's Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) program provided the grant funding. Awardees will use the funds to implement evidence-based and informed intervention strategies proven to increase colorectal cancer screening rates, the firm said.
September 21, 2022
USPSTF: more evidence needed on diabetes screening
By
LabPulse.com staff writers
The Task Force concluded that more research is needed to recommend for or against screening children and adolescents without signs or symptoms.
September 12, 2022
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
By
Leo O'Connor
Dear LabPulse.com member,
August 24, 2022
Quest Diagnostics launches HCV obstetrics panel
By
LabPulse.com staff writers
The company developed the new test panel to include HCV antibody testing with a reflex to quantitative real-time PCR testing, in response to findings from a health trends study published in Obstetrics & Gynecology.
August 16, 2022
Bionano touts study on optical genome mapping
By
LabPulse.com staff writers
The results were published July 21 in the Journal of Neurology.
August 11, 2022
Foundation Medicine highlights lung cancer study results
By
LabPulse.com staff writers
The findings are from the Prospective Clinicogenomic (PCG) study and were published August 5 in the Journal of Thoracic Oncology Clinical and Research Reports.
August 7, 2022
Guardant Health nabs coverage for liquid biopsy MRD test
By
LabPulse.com staff writers
The Guardant Reveal test detects circulating tumor DNA (ctDNA) in blood after surgery to help oncologists identify cancer patients with residual or recurring disease who may benefit most from adjuvant therapy.
August 1, 2022
AACC sees rise in impact of medical laboratory journal
By
LabPulse.com staff writers
The impact factor places it in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology, AACC said.
July 20, 2022
Veracyte genomic test classifies lung cancer risk in study
By
Dexter Johnson
In a study published in the journal PLOS One, a group of researchers has clinically confirmed that Veracyte's Percepta Genomic Sequencing Classifier (GSC) can accurately classify lung cancer risk from inconclusive samples taken in a bronchoscopy.
July 19, 2022
Previous Page
Page 2 of 9
Next Page
